Evexia Lifecare is a fresh entity in the market of medicine and healthcare. Their mission is to create the perfect health products you need. This report helps us explore the routes they might take to earn money, some of their innovation plans, and the likely share price range they may trade in from year 2025 to 2030. Also, we will give replies to the most common questions about the company.
About the Company
Evexia Lifecare Limited produces and markets medicines. They create a wide variety of medicines which are used for different diseases. They also want to innovate and make the world better by increasing the access to healthcare.
Important Money Facts
- Company worth: ₹578.22 Crores
- P/E Ratio: 47.60
- Highest price last year: ₹4.40
- Lowest price last year: ₹1.94
- Price now: ₹3.09
The price of the shares rose by 35.53% the previous year. One of the results is that the company is doing better and more investors are interested in buying stocks.
Who Owns the Shares
- Regular people and others: 92.47%
- Company owners: 5.87%
- Foreign investors: 1.49%
- Other Indian companies: 0.13%
- Mutual Funds: 0.04%
What the Share Price Might Be (2025-2030)
Year | Share Price Target |
---|---|
2025 | ₹5 |
2026 | ₹8 |
2027 | ₹11 |
2028 | ₹14 |
2029 | ₹17 |
2030 | ₹20 |
Why Evexia Lifecare Might Grow
- They want to sell in more places
- They spend money on making new medicines
- A lot of the common people buy shares instead of the big investors
- More foreign companies are buying shares
- They're getting better at running the company
Good Points and Problems
Good Points:
- Much gain in share price occurred last year
- Besides, most common people buy shares in payback
- More foreign companies are interested
- They are working on research and development
Problems:
- Company owners don't own a large number of shares
- The price/earnings ratio is high at 47.60
- They don't give much money back to people who buy shares
Common Questions
- What will be the share price by 2025?
Around ₹5. The company is expanding, therefore, the company is doing better. - Why did company owners sell some shares?
They might require financial assistance or choose to reinvest the money. Ultimately, it's the best thing to happen because they paid off all of their debts. - Why are a lot of the common people buying these shares?
They are less expensive and the promise of firm growth is holding the market record, while health companies are in high demand. - Is the number of foreign companies buying shares increasing?
Exactly, foreign companies now keep 1.49% instead of 1.03% which is a sign that they believe in the company's success in the future. - Is it okay to have Evexia Lifecare shares for a long time?
The company can increase more shares selling in other cities and selling abroad. Although, there are a number of adversity such as the high P/E ratio and less company's owners shares. - What will be the share price in 2030?
Probably around ₹20, if the company continues to show growth and sell in more places. - Why doesn't the company deliver money to the people who buy shares?
They could be using the money to grow the company instead of using it to make new pharma or starting new branches. - What are the risks of buying Evexia Lifecare shares?
They are the main risk to the fact that stocks would be getting costlier and most company owners do not possess the stocks and they don't give the money back to people who buy shares.
Conclusion
Lifecare, the health care industry is one of the most rapidly growing industries. It may progress in the direction of healthcare and medicine if the company tries harder to rise through the visibility of its products and services. People buy many shares, which is good. Those people should be aware of the risks associated with this before making their decisions.